News Pfizer’s Danuglipron for Obesity and Type 2 Diabetes Pfizer Inc. has announced plans to focus on developing its oral candidate danuglipron as a treatment for obesity and type 2 diabetes. This ... By Artur FernandoJune 28, 20230